The Baroness Greenfield | |
---|---|
Born | Susan Adele Greenfield 1 October 1950 |
Alma mater | St Hilda's College, Oxford |
Spouse | [2] |
Awards | CBE, Knight of the Legion of Honour |
Scientific career | |
Institutions | |
Thesis | Origins of acetylcholinesterase in cerebrospinal fluid (1977) |
Doctoral advisor | Anthony David Smith [3] |
Website | www |
Susan Adele Greenfield, Baroness Greenfield, CBE , FRCP [4] (born 1 October 1950) is an English scientist, writer, broadcaster and member of the House of Lords (since 2001). Her research has focused on the treatment of Parkinson's disease and Alzheimer's disease. She is also interested in the neuroscience of consciousness [5] and the impact of technology on the brain. [6]
Greenfield is a senior research fellow at Lincoln College, Oxford; [7] she was a professor of Synaptic Pharmacology.[ citation needed ]
Greenfield was chancellor of Heriot-Watt University in Edinburgh between 2005 and 2013. [8] From 1998 to 2010, she was director of the Royal Institution of Great Britain. [9] In September 2013, she co-founded the biotech company Neuro-bio Ltd, where she is chief executive officer.
Greenfield's mother, Doris (née Thorp), was a dancer and a Christian, and her father, Reginald Myer Greenfield, was an electrician who was the son of a Yiddish-speaking Jewish immigrant from Austria; her grandmothers never spoke to each other and she said of them, "the prejudice was equally vociferous on both sides". [10] [11]
She attended the Godolphin and Latymer School, where she took A levels in Latin, Greek and ancient history, and maths. The first member of her immediate family to go to university, she was initially admitted to St Hilda's College to read Philosophy and Psychology, but changed course and graduated with a first-class degree in experimental psychology. [11] [12] As a Senior Scholar at St Hugh's College, Oxford, [13] she completed her DPhil degree in 1977 under the supervision of Anthony David Smith on the Origins of acetylcholinesterase in cerebrospinal fluid . [3]
She then held a junior research fellowship at Green College, Oxford between 1981 and 1984. [14]
Greenfield's research is focused on brain physiology, particularly on the brain mechanisms of Parkinson's and Alzheimer's diseases. She is also known for her role in popularising science. Greenfield has written several books about the brain, regularly gives public lectures, and appears on radio and television. [15]
Since 1976, Greenfield has published approximately 200 papers in peer-reviewed journals, including studies on brain mechanisms involved in addiction and reward, [16] [17] [18] [19] [20] relating to dopamine systems and other neurochemicals. [21] [22] She investigated the brain mechanisms underlying attention deficit hyperactivity disorder (ADHD) [22] [23] as well as the impact of environmental enrichment. [24]
In 1994, she was the first woman to give the Royal Institution Christmas Lectures, then sponsored by the BBC. Her lectures were titled "Journey to the centre of the brain". [25] She was appointed Director of the Royal Institution in 1998. [26] The post was abolished in 2010. [27] The Royal Institution had found itself in a financial crisis following a £22m development programme led by Greenfield and the board. The project ended £3 million in debt. [28] [29] Greenfield subsequently announced that she would be taking her employers to an employment tribunal and her claim would include discrimination. [30] The case was settled out of court. [31]
Greenfield's two main positions at Oxford were Tutorial Fellow in Medicine at Lincoln College Oxford, [7] and Professor of Synaptic Pharmacology.[ citation needed ] Between 1995 and 1999, she gave public lectures as Gresham Professor of Physic in London. Greenfield was Adelaide's Thinker in Residence for 2004 and 2005. [32]
As a result of her recommendations,[ citation needed ] South Australian Premier Mike Rann made a major funding commitment, backed by the state and federal governments and the private sector, to establish the Royal Institution of Australia and the Australian Science Media Centre in Adelaide. [33]
She has explored the relevance of neuroscience knowledge to education [34] and has used the phrase "mind change", [35] an umbrella term comparable to "climate change", encompassing diverse issues involved in the impact of the 21st-century environment on the brain. [36]
In 2013 she co-founded the biotech company Neuro-Bio Ltd which develops diagnostic tests and therapeutics for Alzheimer's disease. The company has found that the C terminus of acetylcholinesterase can be cleaved and that the resulting peptide can kill neurons; the company has also found that a cyclic peptide analogue could prevent that neuronal death. [37] The company raised around $4 million in 2017. [38]
Greenfield sits in the Parliament of the United Kingdom in the House of Lords as a crossbencher, having no formal political affiliation. [39] Records of Greenfield's activity in the House of Lords indicate abstention on a range of issues. [40] She has spoken on a variety of topics, [41] including education, drugs, and economic empowerment for women. [42]
In 2013, Greenfield published a dystopian science-fiction novel, 2121: A Tale from the Next Century, telling the story of videogame-playing hedonists and their conflict with "Neo-Puritans". [43]
In 2014, Greenfield published a popular science book called Mind Change: How Digital Technologies are Leaving their Mark on our Brains, describing her ideas about the impact of digital technology. [44]
Greenfield has expressed concerns that internet usage may modify the brain structures of youngsters. [45] [46]
She has had controversy surrounding her opinions on the relationship between technology use and Autism Spectrum Disorder. She originally linked the increase in Autism Spectrum Disorder diagnosis to increased screen-time in a 2011 New Scientist article,. [47] She defended this claim in 2014, in an interview with Stephen Sackur, on the BBC show HARDTalk, in which she claims to have collated 500 articles "in support of the possible problematic effects" of technology-use. [48]
She noted that Public Health England had related social networking and multiplayer online games to "lower levels of wellbeing", and believed that evidence pointed to a "dose response" relationship, "where each additional hour of viewing increases the likelihood of experiencing socio-emotional problems". [49] She believed this raised questions about where to draw the boundaries between beneficial and harmful use of such technology, saying that "it would be surprising if many hours per day of screen activity did not influence this neuroplasticity". [50]
As of 2016, Greenfield has 32 honorary degrees; [51] has received awards including the Royal Society's Michael Faraday Prize. She has been elected to an Honorary Fellowship of the Royal College of Physicians [52] and the London Science Museum. [53]
In 2006 she was made an Honorary Fellow of the British Science Association [54] and was the Honorary Australian of the Year. [55]
In January 2000, Greenfield received a CBE [56] for her contribution to the public understanding of science. [4] Later that year, she was named Woman of the Year [57] by The Observer . In 2001, she became a Life Peer under the House of Lords Appointments Commission system, [58] as Baroness Greenfield, of Ot Moor, Oxfordshire. [4] [59] Like the other people's peers she was self-nominated. [58]
In 2003, she was appointed a Knight of the Legion of Honour by the French Government. [52] In 2010 she was awarded the Australian Society for Medical Research Medal. [60] She received the British Inspiration award for Science and Technology in 2010. [61]
She is a patron of Alzheimer's Research UK [62] and of Dignity in Dying. [63] She is a founder and trustee of the charity Science for Humanity, a network of scientists, researchers and technologists that collaborates with not-for-profit organisations to create practical solutions to the everyday problems of developing communities. [64]
Greenfield was married to the University of Oxford professor Peter Atkins from 1991 until their divorce in 2005. [2]
Steven Peter Russell Rose is an English neuroscientist, author, and social commentator. He is an emeritus professor of biology and neurobiology at the Open University and Gresham College, London.
Susan Margaret Black, Baroness Black of Strome, is a Scottish forensic anthropologist, anatomist and academic. She was the Pro Vice-Chancellor for Engagement at Lancaster University and is past President of the Royal Anthropological Institute of Great Britain and Ireland. From 2003 to 2018 she was Professor of Anatomy and Forensic Anthropology at the University of Dundee. She is President of St John's College, Oxford.
Dame Uta Frith is a German-British developmental psychologist and emeritus professor in cognitive development at the Institute of Cognitive Neuroscience at University College London (UCL). She pioneered much of the current research into autism and dyslexia. Her book Autism: Explaining the Enigma introduced the cognitive neuroscience of autism. She is credited with creating the Sally–Anne test along with fellow scientists Alan Leslie and Simon Baron-Cohen. Among students she has mentored are Tony Attwood, Maggie Snowling, Simon Baron-Cohen and Francesca Happé.
Dame Nancy Jane Rothwell is a British physiologist. She served as president and vice-chancellor of the University of Manchester from 2010 to 2024, having deputised in both roles until January 2010.
Sir John Anthony Hardy is a human geneticist and molecular biologist at the Reta Lila Weston Institute of Neurological Studies at University College London with research interests in neurological diseases.
Trevor William RobbinsCBE FRS FMedSci is a professor of cognitive neuroscience and the former Head of the Department of Psychology at the University of Cambridge. Robbins interests are in the fields of cognitive neuroscience, behavioural neuroscience and psychopharmacology.
Cordelia Fine is a Canadian-born British philosopher of science, psychologist, and writer. She is a full professor in the History and Philosophy of Science programme at the University of Melbourne, Australia. Fine has written three popular science books on the topics of social cognition, neuroscience, and the popular myths of sex differences. Her latest book, Testosterone Rex, won the Royal Society Science Book Prize, 2017. She has authored several academic book chapters and numerous academic publications. Fine is also noted for coining the term 'neurosexism'.
The Human Connectome Project (HCP) is a five-year project sponsored by sixteen components of the National Institutes of Health, split between two consortia of research institutions. The project was launched in July 2009 as the first of three Grand Challenges of the NIH's Blueprint for Neuroscience Research. On September 15, 2010, the NIH announced that it would award two grants: $30 million over five years to a consortium led by Washington University in St. Louis and the University of Minnesota, with strong contributions from University of Oxford (FMRIB) and $8.5 million over three years to a consortium led by Harvard University, Massachusetts General Hospital and the University of California Los Angeles.
Andrea Hilary Brand is the Herchel Smith Professor of Molecular Biology and a Fellow of Jesus College, Cambridge. She heads a lab investigating nervous system development at the Gurdon Institute and the Department of Physiology, Development and Neuroscience. She developed the GAL4/UAS system with Norbert Perrimon which has been described as “a fly geneticist's Swiss army knife”.
Barbara Jacquelyn Sahakian, is professor of clinical neuropsychology at the department of psychiatry and Medical Research Council (MRC)/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge. She is also an honorary clinical psychologist at Addenbrooke's Hospital, Cambridge. She has an international reputation in the fields of cognitive psychopharmacology, neuroethics, neuropsychology, neuropsychiatry and neuroimaging.
Carol A. Barnes is an American neuroscientist who is a Regents' Professor of psychology at the University of Arizona. Since 2006, she has been the Evelyn F. McKnight Chair for Learning and Memory in Aging and is director of the Evelyn F. McKnight Brain Institute. Barnes has been president of the Society for Neuroscience and is a Fellow of the American Association for the Advancement of Science, and foreign member of the Royal Norwegian Society of Sciences and Letters. She was elected to the National Academy of Sciences in 2018.
Maria Grazia Spillantini is Professor of Molecular Neurology in the Department of Clinical Neurosciences at the University of Cambridge. She is most noted for identifying the protein alpha-synuclein as the major component of Lewy bodies, the characteristic protein deposit found in the brain in Parkinson's disease and dementia with Lewy bodies. She has also identified mutations in the MAPT gene as a heritable cause for frontotemporal dementia.
Francesca Gabrielle Elizabeth Happé is Professor of Cognitive Neuroscience and Director of the MRC Social, Genetic and Developmental Psychiatry Centre at the Institute of Psychiatry, Psychology and Neuroscience, King's College London. Her research concerns autism spectrum conditions, specifically the understanding social cognitive processes in these conditions.
Sarah-Jayne Blakemore is Professor of Psychology and Cognitive Neuroscience at the University of Cambridge and co-director of the Wellcome Trust PhD Programme Neuroscience at University College London.
Katherine Jane Willis, Baroness Willis of Summertown, is a British biologist, academic and life peer, who studies the relationship between long-term ecosystem dynamics and environmental change. She is Professor of Biodiversity in the Department of Biology and Pro-Vice-Chancellor at the University of Oxford, and an adjunct professor in biology at the University of Bergen. In 2018 she was elected Principal of St Edmund Hall, and took up the position from 1 October. She held the Tasso Leventis Chair of Biodiversity at Oxford and was founding Director, now Associate Director, of the Biodiversity Institute Oxford. Willis was Director of Science at the Royal Botanic Gardens, Kew from 2013 to 2018. Her nomination by the House of Lords Appointments Commission as a crossbench life peer was announced on 17 May 2022.
Sophie Kerttu Scott is a British neuroscientist and Wellcome Trust Senior Fellow at University College London (UCL). Her research investigates the cognitive neuroscience of voices, speech and laughter particularly speech perception, speech production, vocal emotions and human communication. She also serves as director of UCL's Institute of Cognitive Neuroscience.
Daphna Joel is an Israeli neuroscientist and advocate for "neurofeminism". She is best known for her research which claims that there is no such thing as a "male brain" or a "female brain". Joel's research has been criticized by other neuroscientists who argue that male and female brains, on average, show distinct differences and can be classified with a high level of accuracy. Joel is a member of The NeuroGenderings Network, an international group of researchers in gender studies and neuroscience. They are critical of what they call neurosexism in the scientific community. Joel has given lectures on her work in both scientific and lay conventions around the world.
Marianne Fillenz was a Neuroscientist at the University of Oxford.
Roshan Cools is a Professor of Cognitive Neuropsychiatry at Radboud University Nijmegen. She is interested in the motivational and cognitive control of human behaviour and how it is impacted by neuromodulation. She was elected to the Royal Netherlands Academy of Arts and Sciences in 2018.
Stephanie J. Cragg is a British physiologist who is Professor of Neuroscience at the University of Oxford. She holds a joint appointment as Professor in the University Department of Physiology, Anatomy and Genetics and as a Fellow, Director of Studies and Tutor for Medicine at the college Christ Church, Oxford.